Clinical trial
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or…
NCT00496236 · GenVec, Industry · Completed
Key facts
| NCT number | NCT00496236 |
|---|---|
| Title | Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer |
| Official title | A Phase I/II Safety, Tolerability and "Proof of Concept" Study of Radiotherapy, Cetuximab, and Intratumoral Injections of TNFerade™ Biologic (AdGVEGR.TNF.11D) for Elderly or Frail Patients or Intermediate Stage Patients With Head and Neck Cancer |
| Lead sponsor | GenVec, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Head and Neck Neoplasms |
| Intervention type | Drug |
| Interventions | TNFerade biologic |
| First posted | Jul 4, 2007 |
| Last update posted | Feb 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: